34
Views
1
CrossRef citations to date
0
Altmetric
Original Scientific Papers

Which patients with coronary artery disease should include oral nitrates on their discharge medication list?

, , , , , , , , , , , , & ORCID Icon show all
Pages 136-148 | Received 07 Jun 2023, Accepted 11 Oct 2023, Published online: 14 Nov 2023

References

  • Malakar AK, Choudhury D, Halder B, et al. A review on coronary artery disease, its risk factors, and therapeutics. J Cell Physiol. 2019;234(10):16812–16823. doi:10.1002/jcp.28350.
  • Bhatnagar P, Wickramasinghe K, Williams J, et al. The epidemiology of cardiovascular disease in the UK 2014. Heart. 2015;101(15):1182–1189. doi:10.1136/heartjnl-2015-307516.
  • Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics-2016 update: a report from the american heart association. Circulation. 2016;133(4):e38–e360. doi:10.1161/CIR.0000000000000350.
  • Parker JD, Parker JO. Nitrate therapy for stable angina pectoris. N Engl J Med. 1998;338(8):520–531. doi:10.1056/NEJM199802193380807.
  • Munzel T, Feil R, Mulsch A, et al. Physiology and pathophysiology of vascular signaling controlled by guanosine 3′,5′-cyclic monophosphate-dependent protein kinase [corrected]. Circulation. 2003;108(18):2172–2183. doi:10.1161/01.CIR.0000094403.78467.C3.
  • Kapil V, Webb AJ, Ahluwalia A. Inorganic nitrate and the cardiovascular system. Heart. 2010;96(21):1703–1709. doi:10.1136/hrt.2009.180372.
  • Wimalawansa SJ. Nitric oxide: new evidence for novel therapeutic indications. Expert Opin Pharmacother. 2008;9(11):1935–1954. doi:10.1517/14656566.9.11.1935.
  • Pragani MA, Desai KP, Morrone D, et al. The role of nitrates in the management of stable ischemic heart disease: a review of the current evidence and guidelines. Rev Cardiovasc Med. 2017;18(1):14–20. doi:10.3909/ricm0857.
  • Kimchi A, Lee G, Amsterdam E, et al. Increased exercise tolerance after nitroglycerin oral spray: a new and effective therapeutic modality in angina pectoris. Circulation. 1983;67(1):124–127. doi:10.1161/01.cir.67.1.124.
  • Yiu KH, Pong V, Siu CW, et al. Long-term oral nitrate therapy is associated with adverse outcome in diabetic patients following elective percutaneous coronary intervention. Cardiovasc Diabetol. 2011;10(1):52. doi:10.1186/1475-2840-10-52.
  • Yager N, Konduru S, Torosoff M. Nitrates as a marker of multiple co-morbidities and increased mortality in patients undergoing percutaneous coronary intervention (PCI. Cureus. 2022;14(3):e23520. doi:10.7759/cureus.23520.
  • Yoon YH, Ahn JM, Kang DY, et al. Impact of SYNTAX score on 10-Year outcomes after revascularization for left main coronary artery disease. JACC Cardiovasc Interv. 2020;13(3):361–371. doi:10.1016/j.jcin.2019.10.020.
  • Kosugi M, Nakagomi A, Shibui T, et al. Effect of long-term nitrate treatment on cardiac events in patients with vasospastic angina. Circ J. 2011;75(9):2196–2205. doi:10.1253/circj.cj-11-0056.
  • Takahashi J, Nihei T, Takagi Y, et al. Prognostic impact of chronic nitrate therapy in patients with vasospastic angina: multicentre registry study of the Japanese coronary spasm association. Eur Heart J. 2015;36(4):228–237. doi:10.1093/eurheartj/ehu313.
  • Kim CH, Park TK, Cho SW, et al. Impact of different nitrate therapies on long-term clinical outcomes of patients with vasospastic angina: a propensity score-matched analysis. Int J Cardiol. 2018;252:1–5. doi:10.1016/j.ijcard.2017.07.031.
  • Schwarz K, Singh S, Parasuraman SK, et al. Inorganic nitrate in angina study: a randomized double-blind placebo-controlled trial. JAHA. 2017;6(9):e006478. doi:10.1161/JAHA.117.006478.
  • Boden WE, Finn AV, Patel D, et al. Nitrates as an integral part of optimal medical therapy and cardiac rehabilitation for stable angina: review of current concepts and therapeutics. Clin Cardiol. 2012;35(5):263–271. doi:10.1002/clc.21993.
  • Gayet JL, Paganelli F, Cohen-Solal A. Update on the medical treatment of stable angina. Arch Cardiovasc Dis. 2011;104(10):536–544. doi:10.1016/j.acvd.2011.08.001.
  • Moro MA, Russel RJ, Cellek S, et al. CGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase. Proc Natl Acad Sci USA. 1996;93(4):1480–1485. doi:10.1073/pnas.93.4.1480.
  • Hink U, Daiber A, Kayhan N, et al. Oxidative inhibition of the mitochondrial aldehyde dehydrogenase promotes nitroglycerin tolerance in human blood vessels. J Am Coll Cardiol. 2007;50(23):2226–2232. doi:10.1016/j.jacc.2007.08.031.
  • Daiber A, Mulsch A, Hink U, et al. The oxidative stress concept of nitrate tolerance and the antioxidant properties of hydralazine. Am J Cardiol. 2005;96(7B):25i–36i. doi:10.1016/j.amjcard.2005.07.030.
  • Fayers KE, Cummings MH, Shaw KM, et al. Nitrate tolerance and the links with endothelial dysfunction and oxidative stress. Br J Clin Pharmacol. 2003;56(6):620–628. doi:10.1046/j.1365-2125.2003.01946.x.
  • Gwag HB, Yang JH, Park TK, et al. Uric acid level has a u-shaped association with clinical outcomes in patients with vasospastic angina. J Korean Med Sci. 2017;32(8):1275–1280. doi:10.3346/jkms.2017.32.8.1275.
  • Pitocco D, Di Stasio E, Romitelli F, et al. Hypouricemia linked to an overproduction of nitric oxide is an early marker of oxidative stress in female subjects with type 1 diabetes. Diabetes Metab Res Rev. 2008;24(4):318–323. doi:10.1002/dmrr.814.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.